Announcement on Resignation of Independent Director
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
Hainan Huluwa Pharmaceutical Group Co. Ltd. has announced the resignation of an independent director.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Hainan Huluwa Pharmaceutical
- Announcement on Concurrent Implementation of Other Risk Warnings for the Company’s Shares
- Announcement on Pledge of Partial Shares of Shareholder
- Announcement on Judicial Freeze of Part of the Controlling Shareholder's Shares, Progress in Enforcement, and Execution of Settlement Agreement
- Announcement on Proposed Inclusion of Company Drugs in the Centralized Volume Procurement of National Chinese Patent Medicine Procurement Alliance (4th Round)
- Indicative Announcement on the Company Being Subject to Compulsory Enforcement
Later from Hainan Huluwa Pharmaceutical
- Announcement on Obtaining the Drug Registration Certificate for Zoledronic Acid Concentrate for Injection
- Announcement on Freezing Release of Some Shares of Controlling Shareholder
- Announcement on Pledge of Partial Shares of Controlling Shareholder
- Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Potassium Chloride Oral Solution
- Announcement on Change of Sponsor Representative for Continuous Supervision
Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.
Follow Hainan Huluwa Pharmaceutical